Attenuation of telomerase activity does not increase sensitivity of human melanoma cells to anticancer agents

M. Folini, C. De Marco, L. Orlandi, M. G. Daidone, N. Zaffaroni

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

In tumour cells, replicative immortality is attained through stabilisation of telomeres by telomerase. Recent evidence suggests that telomerase plays an anti-apoptotic role. Since apoptosis is the primary mode of cell death induced by several drugs, telomerase could be involved in determining the chemosensitivity profile of tumour cells. We investigated whether inhibition of telomerase activity through a hammerhead ribozyme targeting the RNA template of telomerase influences the susceptibility of human melanoma cells to a variety of anticancer agents (platinum compounds, taxanes, topoisomerase I inhibitors). The ribozyme sequence was inserted into an expression vector and the JR8 human melanoma cell line was transfected with it. The cell clones obtained showed a reduced telomerase activity. Growth inhibition curves generated after exposure of ribozyme-transfectant clones to individual drugs were superimposable to those obtained from parental cells. Moreover, telomerase inhibition did not promote apoptosis as a cellular response to drug treatment. Overall, our results indicate that downregulation of telomerase activity does not increase the sensitivity of melanoma cells to anticancer drugs. Copyright (C) 2000 Elsevier Science Ltd.

Original languageEnglish
Pages (from-to)2137-2145
Number of pages9
JournalEuropean Journal of Cancer
Volume36
Issue number16
DOIs
Publication statusPublished - 2000

Fingerprint

Telomerase
Antineoplastic Agents
Melanoma
Catalytic RNA
Pharmaceutical Preparations
Clone Cells
Topoisomerase I Inhibitors
Platinum Compounds
Apoptosis
Taxoids
Telomere
Neoplasms
Cell Death
Down-Regulation
Cell Line
Growth

Keywords

  • Apoptosis
  • Drug sensitivity
  • Melanoma cells
  • Ribozyme
  • Telomerase
  • Telomere

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Attenuation of telomerase activity does not increase sensitivity of human melanoma cells to anticancer agents. / Folini, M.; De Marco, C.; Orlandi, L.; Daidone, M. G.; Zaffaroni, N.

In: European Journal of Cancer, Vol. 36, No. 16, 2000, p. 2137-2145.

Research output: Contribution to journalArticle

@article{d08b7f482a61456789886119df748ead,
title = "Attenuation of telomerase activity does not increase sensitivity of human melanoma cells to anticancer agents",
abstract = "In tumour cells, replicative immortality is attained through stabilisation of telomeres by telomerase. Recent evidence suggests that telomerase plays an anti-apoptotic role. Since apoptosis is the primary mode of cell death induced by several drugs, telomerase could be involved in determining the chemosensitivity profile of tumour cells. We investigated whether inhibition of telomerase activity through a hammerhead ribozyme targeting the RNA template of telomerase influences the susceptibility of human melanoma cells to a variety of anticancer agents (platinum compounds, taxanes, topoisomerase I inhibitors). The ribozyme sequence was inserted into an expression vector and the JR8 human melanoma cell line was transfected with it. The cell clones obtained showed a reduced telomerase activity. Growth inhibition curves generated after exposure of ribozyme-transfectant clones to individual drugs were superimposable to those obtained from parental cells. Moreover, telomerase inhibition did not promote apoptosis as a cellular response to drug treatment. Overall, our results indicate that downregulation of telomerase activity does not increase the sensitivity of melanoma cells to anticancer drugs. Copyright (C) 2000 Elsevier Science Ltd.",
keywords = "Apoptosis, Drug sensitivity, Melanoma cells, Ribozyme, Telomerase, Telomere",
author = "M. Folini and {De Marco}, C. and L. Orlandi and Daidone, {M. G.} and N. Zaffaroni",
year = "2000",
doi = "10.1016/S0959-8049(00)00295-1",
language = "English",
volume = "36",
pages = "2137--2145",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "Elsevier Ltd",
number = "16",

}

TY - JOUR

T1 - Attenuation of telomerase activity does not increase sensitivity of human melanoma cells to anticancer agents

AU - Folini, M.

AU - De Marco, C.

AU - Orlandi, L.

AU - Daidone, M. G.

AU - Zaffaroni, N.

PY - 2000

Y1 - 2000

N2 - In tumour cells, replicative immortality is attained through stabilisation of telomeres by telomerase. Recent evidence suggests that telomerase plays an anti-apoptotic role. Since apoptosis is the primary mode of cell death induced by several drugs, telomerase could be involved in determining the chemosensitivity profile of tumour cells. We investigated whether inhibition of telomerase activity through a hammerhead ribozyme targeting the RNA template of telomerase influences the susceptibility of human melanoma cells to a variety of anticancer agents (platinum compounds, taxanes, topoisomerase I inhibitors). The ribozyme sequence was inserted into an expression vector and the JR8 human melanoma cell line was transfected with it. The cell clones obtained showed a reduced telomerase activity. Growth inhibition curves generated after exposure of ribozyme-transfectant clones to individual drugs were superimposable to those obtained from parental cells. Moreover, telomerase inhibition did not promote apoptosis as a cellular response to drug treatment. Overall, our results indicate that downregulation of telomerase activity does not increase the sensitivity of melanoma cells to anticancer drugs. Copyright (C) 2000 Elsevier Science Ltd.

AB - In tumour cells, replicative immortality is attained through stabilisation of telomeres by telomerase. Recent evidence suggests that telomerase plays an anti-apoptotic role. Since apoptosis is the primary mode of cell death induced by several drugs, telomerase could be involved in determining the chemosensitivity profile of tumour cells. We investigated whether inhibition of telomerase activity through a hammerhead ribozyme targeting the RNA template of telomerase influences the susceptibility of human melanoma cells to a variety of anticancer agents (platinum compounds, taxanes, topoisomerase I inhibitors). The ribozyme sequence was inserted into an expression vector and the JR8 human melanoma cell line was transfected with it. The cell clones obtained showed a reduced telomerase activity. Growth inhibition curves generated after exposure of ribozyme-transfectant clones to individual drugs were superimposable to those obtained from parental cells. Moreover, telomerase inhibition did not promote apoptosis as a cellular response to drug treatment. Overall, our results indicate that downregulation of telomerase activity does not increase the sensitivity of melanoma cells to anticancer drugs. Copyright (C) 2000 Elsevier Science Ltd.

KW - Apoptosis

KW - Drug sensitivity

KW - Melanoma cells

KW - Ribozyme

KW - Telomerase

KW - Telomere

UR - http://www.scopus.com/inward/record.url?scp=0033815904&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033815904&partnerID=8YFLogxK

U2 - 10.1016/S0959-8049(00)00295-1

DO - 10.1016/S0959-8049(00)00295-1

M3 - Article

C2 - 11044653

AN - SCOPUS:0033815904

VL - 36

SP - 2137

EP - 2145

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 16

ER -